A placebo-controlled study of Kava kava in generalized anxiety disorder

International Clinical Psychopharmacology

Volumn 17, Issue 4, 2002, Pages 185-188

  Connor, Kathryn M ^a   Davidson, J R T ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Generalized anxiety disorder; Kava kava; Piper methysticum; Randomized controlled clinical trial

Indexed keywords

KAVA; KAVAPURE; PLACEBO;

ADULT; AGED; ANXIETY NEUROSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF EVALUATION; ANXIETY DISORDER; DOUBLE BLIND PROCEDURE; MIDDLE AGED; OUTPATIENT; PHYTOTHERAPY; PSYCHOLOGICAL RATING SCALE;

ANXIETY DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; KAVA; MALE; MIDDLE AGED; OUTPATIENTS; PHYTOTHERAPY; PSYCHIATRIC STATUS RATING SCALES;

EID: 0035985915     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200207000-00005     Document Type: Article

References (12)

1. The Self-Assessment of Resilience and Anxiety (SARA): Psychometric properties
2. Effect of kava extract and individual kavapyrones on neurotransmitter levels in the nucleus acumbens of rats
3. Adverse effects profile of kava
4. The assessment of anxiety states by rating
5. Kavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain
6. Generalized anxiety disorder in women. A population-based twin study
7. Efficacy of kava extract for treating anxiety: Systematic review and meta-analysis
8. 3H]-Monoamine uptake inhibition properties of kava pyrones
9. The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10
10. Behandlung von angst-patienten
11. The hospital anxiety and depression scale